Fructose-drinking water induced nonalcoholic fatty liver disease and ultrastructural alteration of hepatocyte mitochondria in Male wistar rat

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Mamikutty, Norshalizah ^a   Thent, Zar Chi ^b   Haji Suhaimi, Farihah ^b  

^a UNIVERSITI TEKNOLOGI MARA   (Malaysia)

^b UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; DRINKING WATER; FRUCTOSE; GLUCOSE; TRIACYLGLYCEROL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY COMPOSITION; CARBOHYDRATE INTAKE; CELL ULTRASTRUCTURE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FLUID INTAKE; GLUCOSE BLOOD LEVEL; LIPID STORAGE; LIVER MITOCHONDRION; LIVER STRUCTURE; LIVER WEIGHT; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; MITOCHONDRIAL VOLUME; MORPHOMETRICS; NONALCOHOLIC FATTY LIVER; NONHUMAN; RAT; TRANSMISSION ELECTRON MICROSCOPY; TRIACYLGLYCEROL BLOOD LEVEL; WISTAR RAT; ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; LIVER CELL; ORAL DRUG ADMINISTRATION; PATHOLOGY; ULTRASTRUCTURE;

ANIMALIA; RATTUS NORVEGICUS;

ADMINISTRATION, ORAL; ANIMALS; DRINKING WATER; FRUCTOSE; HEPATOCYTES; MALE; MITOCHONDRIA, LIVER; NON-ALCOHOLIC FATTY LIVER DISEASE; RATS, WISTAR;

EID: 84939193121     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/895961     Document Type: Article

References (20)

1. J. K. Reddy and M. S. Rao, "Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation," The American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 290, no. 5, pp. G852-G858, 2006.
2. P. Paschos and K. Paletas, "Non-alcoholic fatty liver disease and metabolic syndrome," Hippokratia, vol. 13, no. 1, pp. 9-19, 2009.
3. M. H. Ross and W. Pawlina, Histology: A Text and Atlas, with Correlated Cell and Molecular Biology, Lippincott Williams and Wilkins, Philadelphia, Pa, USA, 6th edition, 2011.
4. X. Ouyang, P. Cirillo, Y. Sautin et al., "Fructose consumption as a risk factor for non-alcoholic fatty liver disease," Journal of Hepatology, vol. 48, no. 6, pp. 993-999, 2008.
5. S. J. Nielsen and B. M. Popkin, "Changes in beverage intake between 1977 and 2001," The American Journal of Preventive Medicine, vol. 27, no. 3, pp. 205-210, 2004.
6. M. S. Segal, E. Gollub, and R. J. Johnson, "Is the fructose index more relevant with regards to cardiovascular disease than the glycemic index?" European Journal of Nutrition, vol. 46, no. 7, pp. 406-417, 2007.
7. R. J. Johnson, M. S. Segal, Y. Sautin et al., "Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease1-3," The American Journal of Clinical Nutrition, vol. 86, no. 4, pp. 899-906, 2007.
8. P. J. Havel, "Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism," Nutrition Reviews, vol. 63, no. 5, pp. 133-137, 2005.
9. K.-A. Le and L. Tappy, "Metabolic effects of fructose," Current Opinion in Clinical Nutrition and MetabolicCare, vol. 9, no. 4, pp. 469-475, 2006.
10. P. A. Mayes, "Intermediary metabolism of fructose," The American Journal of Clinical Nutrition, vol. 58, no. 5, pp. 754S-765S, 1993.
11. Z. Ackerman, M. Oron-Herman, M. Grozovski et al., "Fructoseinduced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction," Hypertension, vol. 45, no. 5, pp. 1012-1018, 2005.
12. H. Poudyal, F. Campbell, and L. Brown, "Olive leaf extract attenuates cardiac, hepatic, and metabolic changes in high carbohydrate-, high fat-fed rats," The Journal of Nutrition, vol. 140, no. 5, pp. 946-953, 2010.
13. N. Mamikutty, Z. C. Thent, S. R. Sapri, N. N. Sahruddin, M. R. Mohd Yusof, and F. Haji Suhaimi, "The establishment of metabolic syndrome model by induction of fructose drinking water in male Wistar rats," BioMed Research International, vol. 2014, Article ID 263897, 8 pages, 2014.
14. F. Ahmad, I. N. Soelaiman, E. S. Mohd Ramli, M. H. Tan, and F. Haji Suhaimi, "Histomorphometric changes in the perirenal adipocytes of adrenalectomized rats treated with dexamethasone," Clinics, vol. 66, no. 5, pp. 849-853, 2011.
15. S. K. Panchal, L. Ward, and L. Brown, "Ellagic acid attenuates high-carbohydrate, high-fat diet-induced metabolic syndrome in rats," European Journal of Nutrition, vol. 52, no. 2, pp. 559-568, 2013.
16. M. Berthiaume, M. Laplante, W. T. Festuccia et al., "11β- HSD1 inhibition improves triglyceridemia through reduced liver VLDL secretion and partitions lipids toward oxidative tissues," The American Journal of Physiology-Endocrinology and Metabolism, vol. 293, no. 4, pp. E1045-E1052, 2007.
17. Y. Wei, R. S. Rector, J. P. Thyfault, and J. A. Ibdah, "Nonalcoholic fatty liver disease and mitochondrial dysfunction," World Journal of Gastroenterology, vol. 14, no. 2, pp. 193-199, 2008.
18. S. Susan, Grays Anatomy: The Anatomical Basis of Clinical Practice, Churchill Livingstone, Elsevier, 40th edition, 2008.
19. W. Takashi, "Pathology of mitochondria: structural and functional aspects," Borgis-New Medicine, vol. 2, pp. 34-36, 2004.
20. G. C. Farrell and C. Z. Larter, "Nonalcoholic fatty liver disease: from steatosis to cirrhosis," Hepatology, vol. 43, no. 2, pp. S99- S112, 2006.